Articles about Moderna Inc

Immunity generated by the Moderna COVID-19 vaccine lasts for at least six months, and there is no indicator that vaccinated people will need a booster shot, according to a study.

Japan suspended use of about 1.63 million Moderna vaccine doses on Thursday after contamination was found in unused vials, raising concern of a supply shortage as the country tries to accelerate vaccinations amid a COVID-19 surge.

Researchers have found no evidence of the presence of Pfizer or Moderna COVID-19 vaccines in breast milk suggesting that mRNA preventives are safe during lactation.

India has been offered 7.5 million doses of Moderna's COVID-19 vaccine through the COVAX global vaccine sharing program, but it is not clear when the jabs will arrive in the country as a consensus on the indemnity clause is yet to be reached, sources said.

Moderna's COVID-19 vaccine is reportedly expected to reach India in the next few days.

The Drugs Controller General of India (DCGI) has reportedly allowed the pharmaceutical firm Cipla to import the COVID-19 vaccine developed by US-based biotechnology company Moderna Inc.

The Moderna COVID-19 vaccine and an experimental protein-based preventive proved to be safe and showed good antibody response against SARS-CoV-2 in a trial on baby rhesus macaques, scientists said.

The world's leading COVID-19 vaccines, including the ones from Pfizer and Moderna, may offer lasting protection that diminishes the need for frequent booster shots.

The Drugs Controller General of India has scrapped the requirement of local trials for foreign-made coronavirus vaccines - a key move to upscale the dwindling COVID-19 vaccinations in the country.

Pfizer has told the Indian government that its coronavirus vaccine shows "high effectiveness" on the COVID-19 variant prevalent in India as well as on people of Indian ethnicity or nationality.

India may not receive doses of the COVID-19 vaccines developed by Pfizer and Moderna until 2023 as the manufacturers have other commitments.

American pharmaceutical companies Pfizer and Moderna have said they would not sell their coronavirus vaccines directly to the Delhi government, Chief Minister Arvind Kejriwal revealed today.

In the biggest indication that the United States is fast returning to pre-pandemic life, the Centers for Disease Control and Prevention (CDC) has said fully vaccinated people are no longer required to wear masks.

Maharashtra minister Nawab Malik on Thursday claimed that India's French embassy has procured Moderna anti-coronavirus vaccine and it is being administered to its nationals at Navi Mumbai even as only three other vaccines are permitted in India.

The coronavirus vaccines developed by American pharma giant Pfizer, with Germany's BioNTech, and the one manufactured by Moderna, another United States company, reduce the risk of infection even after the first dose, a study has found, reports Reuters.

British pharmaceutical company AstraZeneca Plc has sold its 7.7 percent stake in Moderna Inc., the American pharmaceutical giant, for more than $1 billion, according to a report in The Times.

People who have recovered from COVID-19 may need only one shot as opposed to the recommended two jabs if they are taking the Moderna or Pfizer vaccines, according to a study that suggests ways to minimize doses when supplies are limited.

Johnson & Johnson's (J&J) much-awaited COVID-19 vaccine has reportedly exhibited strong protection against the virus.

US President Joe Biden on Tuesday announced the purchase of additional 200 million doses of coronavirus vaccines as the country reached 25 million COVID-19 infections.

The European Union's medicines agency gave the green light to the Moderna COVID-19 vaccine on Wednesday.

The World Health Organization (WHO) on Thursday granted "emergency validation" to the coronavirus vaccine developed by Pfizer and BioNTech, making it the first vaccine to be given such an approval by the United Nations body.

As vaccines for COVID-19 have started being rolled out in parts of the world, certain myths have been propagated questioning their safety and efficacy.

As the vaccine for COVID-19 had just started rolling out, the worrisome news of the coronavirus mutating has started circulating.

Urging the international community to demand transparency from China about the spread of the coronavirus, the US has accused Beijing of "obstructing" a World Health Organization (WHO) probe into its origin and "peddling" questionable vaccines one year after the disease broke out in Wuhan.

Moderna's COVID-19 vaccine has been approved in the United States, outgoing President Donald Trump announced ahead of the nation's drug regulator.

The US Food and Drug Administration's advisory panel, comprising external experts, has given an emergency use approval to Moderna's COVID-19 vaccine, making it the second drug after Pfizer to receive such an authorization in less than a week.

U.S. officials have said that they are actively negotiating for additional purchases of Pfizer's coronavirus vaccine after they missed the chance to lock in a contract this summer since it was still unclear how well the shots would work.

Moderna's COVID-19 vaccine has been found safe and effective, the United States Food and Drug Administration said in a report on Tuesday.

The Food and Drug Administration (FDA) on Friday authorized Pfizer-BioNTech's COVID-19 vaccine, clearing the way for its mass rollout across the United States.

United States pharmaceutical company Moderna on Monday said that it will seek emergency approval for its COVID-19 vaccine in the US and Europe.

After announcing that their coronavirus vaccine candidate was nearly 70% effective, the University of Oxford and its partner, AstraZeneca, on Wednesday admitted to a manufacturing error, which has now sparked important questions about the results.

The Russian vaccine for COVID-19, called Sputnik V, has been found at least 91% effective in the second interim analysis.

The CEO of the Serum Institute of India (SII), Adar Poonawalla, has said that the institute can roll out 100 million doses of the COVID-19 vaccine by January-February.

The coronavirus vaccine being developed by Oxford University and British pharma giant AstraZeneca is 70% effective, results from large-scale trials have shown, multiple reports said on Monday.

Developing immunity against COVID-19 through repeated low-dose exposures is possible, however, it is not likely, Dr. James Hamblin said while responding to a query in his 'Paging Dr. Hamblin' column in The Atlantic.

Pharmaceutical giant Pfizer and German drugmaker BioNTech on Wednesday said their COVID-19 vaccine has been found 95% effective in final trials.

With heartening news of the coronavirus vaccine coming from different parts of the world, the Indian government is trying to understand which one would be the most feasible for the country.

The United States could begin inoculating its citizens with Pfizer's coronavirus vaccine as early as December, provided the drugmaker submits data from its trial to health regulators, Health Secretary Alex Azar said on Tuesday.

Even as the COVID-19 outbreak has witnessed a downward trend in India, some states have been reporting large spikes in infections, indicating that the pandemic is far from over.

It has been almost a year since the coronavirus pandemic began, yet the virus is far from being brought under control.